{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:23:18Z","timestamp":1785403398252,"version":"3.56.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pituitary adenoma (PA) is a benign neuroendocrine tumor caused by adenohypophysial cells, and accounts for 10%-20% of all primary intracranial tumors. The surgical outcomes and prognosis of giant pituitary adenomas measuring \u22653 cm in diameter differ significantly due to the influence of multiple factors such as tumor morphology, invasion site, pathological characteristics and so on. The aim of this study was to explore the risk factors related to the recurrence or progression of giant and large PAs after transnasal sphenoidal surgery, and develop a predictive model for tumor prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The clinical and follow-up data of 172 patients with large or giant PA who underwent sphenoidal surgery at the Second Affiliated Hospital of Zhejiang University School of Medicine from January 2011 to December 2017 were retrospectively analyzed. The basic clinical information (age, gender, past medical history etc.), imaging features (tumor size, invasion characteristics, extent of resection etc.), and histopathological characteristics (pathological results, Ki-67, P53 etc.) were retrieved. SPSS 21.0 software was used for statistical analysis, and the R software was used to establish the predictive nomogram.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy out of the 172 examined cases (40.7%) had tumor recurrence or progression. The overall progress free survival (PFS) rates of the patients at 1, 3 and 5 years after surgery were 90.70%, 79.65% and 59.30% respectively. Log-rank test indicated that BMI (P &amp;lt; 0.001), Knosp classification (P &amp;lt; 0.001), extent of resection (P\u00a0&amp;lt; 0.001), Ki-67 (P &amp;lt; 0.001), sphenoidal sinus invasion (P = 0.001), Hardy classification (P = 0.003) and smoking history (P = 0.018) were significantly associated with post-surgery recurrence or progression. Cox regression analysis further indicated that smoking history, BMI \u226525 kg\/m<jats:sup>2<\/jats:sup>, Knosp classification grade 4, partial resection and \u22653% Ki-67 positive rate were independent risk factors of tumor recurrence or progression (P &amp;lt; 0.05). In addition, the nomogram and ROC curve based on the above results indicated significant clinical value.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The postoperative recurrence or progression of large and giant PAs is related to multiple factors and a prognostic nomogram based on BMI (\u226525 kg\/m<jats:sup>2<\/jats:sup>), Knosp classification (grade 4), extent of resection (partial resection) and Ki-67 (\u22653%) can predict the recurrence or progression of large and giant PAs after transnasal sphenoidal surgery.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.793337","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T08:27:26Z","timestamp":1639470446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Analysis of Related Factors of Tumor Recurrence or Progression After Transnasal Sphenoidal Surgical Treatment of Large and Giant Pituitary Adenomas and Establish a Nomogram to Predict Tumor Prognosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Yike","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinben","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1159\/000339823","article-title":"Natural History of Postoperative Nonfunctioning Pituitary Adenomas: A Systematic Review and Meta-Analysis","volume":"96","author":"Chen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of Pituitary Adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-1031","article-title":"Management of Endocrine Disease: Clinicopathological Classification and Molecular Markers of Pituitary Tumours for Personalized Therapeutic Strategies","volume":"170","author":"Raverot","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.wneu.2011.02.009","article-title":"Surgical Results of Large and Giant Pituitary Adenomas With Special Consideration of Ophthalmologic Outcomes","volume":"76","author":"M\u00fcsl\u00fcman","year":"2011","journal-title":"World Neurosurg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03665.x","article-title":"Endonasal Transsphenoidal Surgery and Multimodality Treatment for Giant Pituitary Adenomas","volume":"72","author":"de Paiva Neto","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-011-0350-z","article-title":"Volumetric Classification of Pituitary Macroadenomas Predicts Outcome and Morbidity Following Endoscopic Endonasal Transsphenoidal Surgery","volume":"15","author":"Hofstetter","year":"2012","journal-title":"Pituitary"},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/2014.3.JNS131679","article-title":"Endoscopic Endonasal Transsphenoidal Approach to Large and Giant Pituitary Adenomas: Institutional Experienceand Predictors of Extent of Resection","volume":"121","author":"Juraschka","year":"2014","journal-title":"J Neurosurg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-1117","article-title":"Giant GH-Secreting Pituitary Adenomas: Management of Rare and Aggressive Pituitary Tumors","volume":"172","author":"Shimon","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the Treatment of Prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0439-z","article-title":"The Current Role Oftranscranial Surgery in the Management of Pituitary Adenomas","volume":"16","author":"Pratheesh","year":"2013","journal-title":"Pituitary"},{"key":"B12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1288\/00005537-199202000-00016","article-title":"Endoscopic Pituitarytumor Surgery","volume":"102","author":"Jankowski","year":"1992","journal-title":"Laryngoscope"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2552","article-title":"Observation Alone After Transsphenoidal Surgery for Nonfunctioning Pituitary Macroadenoma","volume":"91","author":"Dekkers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/EJE-10-0255","article-title":"Factors Predicting Relapse of Nonfunctioning Pituitary Macroadenomas After Neurosurgery: A Study of 142 Patients","volume":"163","author":"Brochier","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02298","article-title":"Non-Functioning Pituitary Adenoma Database: A Useful Resource to Improve the Clinical Management of Pituitary Tumors","volume":"155","author":"Ferrante","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B16","article-title":"Management of Nonfunctioning Pituitaryadenomas","volume":"129","author":"Sassolas","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.01.028","article-title":"Treatment of Nonfunctional Pituitary Adenoma Postoperative Remnants: Adjuvant or Delayed Gamma Knife Radiosurgery","volume":"100","author":"Sadik","year":"2017","journal-title":"World Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3171\/JNS\/2008\/108\/3\/0525","article-title":"Early Results of Surgery in Patients With Nonfunctioning Pituitary Adenoma and Analysis of the Risk of Tumor Recurrence","volume":"108","author":"Losa","year":"2008","journal-title":"J Neurosurg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.JNS141083","article-title":"Invasion of the Cavernous Sinus Space Inpituitary Adenomas: Endoscopic Verification and its Correlation With an MRI-Based Classification","volume":"122","author":"Micko","year":"2015","journal-title":"J Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1226","article-title":"Clinicopathological Predictive Factors in the Early Remission of Corticotroph Pituitary Macroadenomas in a Tertiary Referral Centre","volume":"174","author":"Witek","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej11-0177","article-title":"Differential Expression of Genes Related to Drug Responsiveness Between Sparsely and Densely Granulated Somatotroph Adenomas","volume":"59","author":"Kato","year":"2012","journal-title":"Endocr J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/EJE-14-0990","article-title":"Expression of Estrogen Receptor Alpha Is Associated With Prolactin Pituitary Tumor Prognosis and Supports the Sex-Related Difference in Tumor Growth","volume":"172","author":"Delgrange","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kaz063","article-title":"Lung Cancer Stigma: Does Smoking History Matter","volume":"54","author":"Williamson","year":"2020","journal-title":"Ann Behav Med Publ Soc Behav Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0965","article-title":"Both Invasivenessand Proliferation Criteria Predict Recurrence of Non-Functioning Pituitary Macroadenomas After Surgery: A Retrospective Analysis of a Monocentric Cohort of 120 Patients","volume":"178","author":"Lelotte","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.06.210","article-title":"Clinical Andpathologic Characteristics Predicted the Postoperative Recurrence and Progression of Pituitary Adenoma: A Retrospective Study With 10 Years Follow-Up","volume":"118","author":"Lv","year":"2018","journal-title":"World Neurosurg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.breast.2013.11.007","article-title":"High Ki-67 Score Is Indicative of a Greater Benefit From Adjuvant Chemotherapy When Added to Endocrine Therapy in Luminal B HER2 Negative and Node-Positive Breast Cancer","volume":"23","author":"Criscitiello","year":"2014","journal-title":"Breast"},{"key":"B27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10143-015-0613-7","article-title":"Endoscopic Versus Microscopic Approach for Surgical Treatment of Acromegaly","volume":"38","author":"Fathalla","year":"2015","journal-title":"Neurosurg Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1976.45.2.0169","article-title":"Anatomy of the Cavernous Sinus. A Microsurgical Study","volume":"45","author":"Harris","year":"1976","journal-title":"J Neurosurg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1413-6","article-title":"Management of Aggressive Pituitary Adenomas and Pituitary Carcinomas","volume":"117","author":"Heaney","year":"2014","journal-title":"JNeurooncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/00006123-200110000-00014","article-title":"Are Nonfunctioningpituitary Adenomas Extending Into the Cavernous Sinus Aggressive and\/or Invasive","volume":"49","author":"Yokoyama","year":"2001","journal-title":"Neurosurgery"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2016.10.013","article-title":"The Association Between Cathepsin K Expressionand Sphenoid Sinus Invasion of Pituitary Adenomas","volume":"97","author":"Liu","year":"2016","journal-title":"Med Hypotheses"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01296-4","article-title":"Predictive Model of Surgical Remission in Acromegaly: Age, Presurgical GH Levels and Knosp Grade as the Best Predictors of Surgical Remission","volume":"44","author":"Araujo-Castro","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-00976-6","article-title":"Predicting Early Post-Operative Remission in Pituitary Adenomas: Evaluation of the Modified Knosp Classification","volume":"22","author":"Buchy","year":"2019","journal-title":"Pituitary"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02688697.2021.1884186","article-title":"Ki-67 Labeling Index and Knosp Classification Ofpituitary Adenomas","volume":"27","author":"Yuhan","year":"2021","journal-title":"Br J Neurosurg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO Classification of Pituitary Tumors","volume":"28","author":"Mete","year":"2017","journal-title":"EndocrPathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7490585","article-title":"Association of Ki-67 Labelling Index and IL-17A With Pituitary Adenoma","volume":"2018","author":"Glebauskiene","year":"2018","journal-title":"BioMed Res Int"},{"key":"B37","article-title":"Evaluation of the Potential of the Ki67 Index to Predict Tumor Evolution in Patients With Pituitary Adenoma","volume":"12","author":"Petry","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization Classification of Tumors of the Pituitarygland: A Summary","volume":"134","author":"Lopes","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1084-y","article-title":"Anew Prognostic Clinicopathological Classification of Pituitary Adenomas: A Multicentric Case-Control Study of 410 Patients With 8 Years Post-Operative Follow-Up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1606602","article-title":"Body Fatness and Cancer\u2013Viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1330554","article-title":"Overweight, Obesity and Height as Risk Factors for Meningioma, Glioma, Pituitary Adenoma and Nerve Sheath Tumor: A Large Population-Based Prospective Cohort Study","volume":"56","author":"Wiedmann","year":"2017","journal-title":"Acta Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1989.71.4.0538","article-title":"Characterization of Insulin-Like Growth Factor I and Epidermal Growth Factor Receptors in Meningioma","volume":"71","author":"Kurihara","year":"1989","journal-title":"J Neurosurg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1054\/ghir.2000.0183","article-title":"Growth Hormone Andinsulin-Like Growth Factor-I: Effects on the Growth of Glioma Cell Lines","volume":"11","author":"Friend","year":"2001","journal-title":"Growth Horm IGF Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1179\/016164105X18151","article-title":"Insulin-Like Growth Factor-I Decreased Etoposide-Induced Apoptosis in Glioma Cells by Increasing Bcl-2 Expression and Decreasing CPP32 Activity","volume":"27","author":"Yin","year":"2005","journal-title":"Neurol Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.14.1194","article-title":"Tobacco Smoke Carcinogens and Lung Cancer","volume":"91","author":"Hecht","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24082","article-title":"Prognostic Value of Continued Smoking on Survival and Recurrence Rates in Patients With Head and Neck Cancer: A Systematic Review","volume":"38","author":"van Imhoff","year":"2016","journal-title":"Head Neck"},{"key":"B47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11255-016-1441-6","article-title":"Impact of Smoking Statusand Cumulative Smoking Exposure on Tumor Recurrence of non-Muscle-Invasive Bladder Cancer","volume":"49","author":"Li","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.08.043","article-title":"Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship With Sex, Size, and Hormonal Immunohistochemical Profile","volume":"120","author":"Batista","year":"2018","journal-title":"World Neurosurg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2014.01.020","article-title":"Results and Risk Factors for Recurrence Following Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenoma","volume":"119","author":"Bodhinayake","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.21037\/gs-21-47","article-title":"Nomogram Predictive Model of Post-Operative Recurrencein non-Functioning Pituitary Adenoma","volume":"10","author":"Lyu","year":"2021","journal-title":"Gland Surg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to Build and Interpret a Nomogram Forcancer Prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in Oncology: More Thanmeets the Eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.793337\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T08:27:29Z","timestamp":1639470449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.793337\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":52,"alternative-id":["10.3389\/fendo.2021.793337"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.793337","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"article-number":"793337"}}